Abstract
Variation is the spice of life or, in the case of evolution, variation is the necessary material on which selection can act to enable adaptation. Karyotypic variation in ploidy (the number of homologous chromosome sets) and aneuploidy (imbalance in the number of chromosomes) are fundamentally different than other types of genomic variants. Karyotypic variation emerges through different molecular mechanisms than other mutational events, and unlike mutations that alter the genome at the base pair level, rapid reversion to the wild type chromosome number is often possible. Although karyotypic variation has long been noted and discussed by biologists, interest in the importance of karyotypic variants in evolutionary processes has spiked in recent years, and much remains to be discovered about how karyotypic variants are produced and subsequently selected.
Introduction
Fungal microbes have emerged as important taxa to study the effect of karyotypic variation on phenotype and fitness (reviewed in [1]). Ploidy variation exists among, as well as within, fungal species and ploidy shifts continue to emerge in surprising places. Variation in ploidy among nuclei that share a common cytoplasm was recently reported in Ashbya gossypii, an otherwise haploid organism [2]. Candida albicans, long considered an obligate diploid, recently was found to generate haploids following passage through a mouse model, and following exposure to the antifungal drug fluconazole [3,4]. Similarly, rare tetraploids have been sampled from clinical isolates of C. albicans [5,6], and polyploid "titan" cells were recently identified in the typically-haploid basidiomycete Cryptococcus neoformans [7,8] (reviewed in [9]). Aneuploid variants also have been documented at appreciable frequencies in many fungal taxa in a diversity of circumstances: within the S. cerevisiae deletion collection constructed by transformation [10], following drug stress in C. albicans [11] and C. neoformans [12], in meiotic spores of C. lusitaniae [13] and through unisexual mating in C. neoformans [14]. Furthermore, it remains possible that the true proportion of karyotypic variants is even higher than currently appreciated, as variants are rapidly eliminated ex vivo due to the growth conditions typically used to propagate cultures in the laboratory.
Here we focus on karyotypic variants that arise mitotically, within a single organism, rather than those formed through conventional means involving sexual conjugation followed by meiotic reductive divisions. We first discuss variations in whole genome ploidy level and then changes due to aneuploidy, focusing on the mechanisms that produced the variation and then on the degree to which they provide a selective advantage under different growth conditions.
Producing ploidy shifts
The mitotic mechanisms by which ploidy variants are produced are dependent on the direction of change. Increases occur through endoreplication, a process in which the genome replicates, but the cell containing it fails to complete mitosis and cytokinesis. Decreases in ploidy occur via a cryptic chromosome loss mechanism, often, if not always, through aneuploid intermediates [3,15,16]. There remains no known mitotic program to undertake a full euploid chromosome set reduction (‘concerted chromosome loss’ [17]), yet the rate at which some reductions in ploidy have been documented in the laboratory indicates that it can not be attributed solely to selection acting on individual chromosome loss events. Ploidy transitions frequently occur within relatively short timescales; they are often detected following fitness assay tests (24–72 h) and short-term experimental evolution passaging (< 200 generations). Convergence towards the historical ploidy level has now been documented in S. cerevisiae [15,18,19], C. albicans [3,16], C. tropicalis [20], and C. neoformans (Gerstein et al., in review). The force behind this 'ploidy-drive' remains cryptic, as there have been few identified fitness differences between ploidy-variant individuals sampled from the same population [21]. The presence of ploidy variants and the rate of ploidy transition is strongly influenced by the environment [2,15,17], yet the link(s) between genotype, phenotype and fitness remain murky.
Does ploidy state provide a selective advantage?
An ongoing topic of debate in evolutionary biology is why one ploidy level should be beneficial over another. As all genomes are subjected to the same basic processes, why is there not a singular "best" ploidy level employed across the tree of life? This question has been addressed using fungal microbes that can be manipulated to generate isogenic “ploidy series”, thereby distinguishing ploidy from differences in genetic background. Predictions generally fall into two categories: short-term influences of ploidy on ecological tolerance and survival, mediated through physiological differences; and long-term (evolutionary) influence of ploidy on the rate of adaptation, mediated through the genetic basis of beneficial mutations (discussed in detail in [22]).
Physiologically, ploidy is frequently correlated with differences in the cell surface area:volume (SA:V) ratio, which decreases as ploidy and cell size increase. Lower ploidy (and a higher SA:V ratio) is predicted to be beneficial under nutrient limitation, yet detrimental when toxins are present in the environment. Overall, these predictions received only mixed support from empirical tests, as highlighted by Zorgo et al. [23]**, who compared many haploid and diploid strains of S. cerevisiae and S. paradoxus. They found that although ploidy × environment interactions were frequent and often evolutionarily conserved, there was not an overall growth advantage for diploids in toxins, or for haploids under nutrient limitation or environmental stress. Thus, no single catch-all explanation accounts for why one ploidy level is ecologically beneficial over another. This result may not be satisfying, but it likely reflects the reality of biology: a large number of factors usually influence growth and survival.
Recent technological advances, in particular flow cytometry coupled with next generation sequencing, now enable researchers to track the genetic basis of adaptation and to test the influence of ploidy on the mutations selected during adaptation. When beneficial mutations arise in diploids or polyploid individuals, their effects are often at least partially masked by the wild-type allele(s) that remain. Thus, haploids may be able to acquire a greater diversity of mutations (as in [24]) or to access different types of mutations. This was recently shown for lines adapting to nutrient limitation: beneficial loss-of-function mutations, which are often recessive, arose more frequently in haploid lines, while diploid lines were enriched for mutations that increase gene expression (and are likely at least partially expressed in heterozygous form, [25]). Thus haploids, which fully express all beneficial mutations, might be expected to adapt faster than diploids. However, depending on the environmental challenge, this may [26], or may not [19], be the case. An increase in ploidy also increases the mutation rate [19], and, if selection is strong, loss of heterozygosity can rapidly convert heterozygous mutations to a homozygous state [27], thereby reducing the difference in the rate of adaptation between haploids (where the effect of recessive beneficial mutations are immediately felt) and higher ploidy levels. Finally, mutations may also have different effect sizes in different ploidy backgrounds, even when present in homozygous form [28]. Taken together, it appears that the relationship between ploidy and adaptation depends heavily on the environment and the particulars of the available mutations. Consistent with this idea, a recent genome-wide tour-de-force by Dunham and co-workers distinguished the effects of aneuploidy from those of mutations acquired in aneuploid strains using a clever system to generate extra copies of chromosome arm segments. They found that aneuploidies could provide adaptive advantages under specific environmental conditions and that the advantages were clearly related to the genes included on the aneuploid segments [29]**.
Slipping into (and out of) aneuploidy
Aneuploidy arises through nondisjunction of single, or a few, chromosomes, and provides a fundamentally different class of adaptive genomic change than point mutations (Figure 1). As chromosome nondisjunction occurs several orders of magnitude more frequently than point mutations, and aneuploidy is more prevalent than shorter range copy number variations, small insertions, or small deletions [30], aneuploidy provides a rapid mechanism to generate diversity upon which selection can act (Figure 1b). Aneuploidy may also act as a stepping-stone to other types of genic mutations if the environmental stress is maintained for many generations. Similar to changes in ploidy, aneuploidy may increase the rate that beneficial mutations can arise within the genome (Figure 1c), either on the chromosome that is aneuploid, or through a general increase in genomic instability. Once a chromosome imbalance is present, the fidelity of chromosome segregation appears to be reduced. Once additional beneficial point mutations are acquired, selection to maintain the aneuploidy will be lost. When the environmental stress is removed, aneuploidy also can be lost more rapidly than other genomic mutations, via a chromosome non-disjunction event (Figure 1d). Thus, aneuploidy provides a highly flexible mechanism to rapidly adapt to a changing environment.
Figure 1.
Aneuploidy can be rapidly selected for or against in permissive environments (blue background) and stressful environments (pink background). A) In a permissive environment the wild-type genotype is more fit (occupies a higher peak on the landscape) than either an aneuploid strain or a mutant strain. B) When in a stress environment, the wild-type genotype is no longer the most fit. Multiple types of mutations can confer a fitness advantage, including a particular aneuploidy and a genic mutation. The width of the arrows indicates the mutational frequency; aneuploidy arises more frequently than any particular genic mutation. C) If the stress environment is maintained over time, aneuploidy can act as a bridge to genic mutations. The mutation rate is increased in aneuploids, due to the extra chromosome copy, and the aneuploidy can be easily lost once a beneficial mutation arises. D) If the environment returns to being permissive, reversion of an aneuploid chromosome via chromosome gain or loss can occur with high frequency. Reversion of genic mutations is a much rarer event.
Chromosomes in aneuploid cells are more prone to nondisjunction events than are chromosomes in euploid cells [16,31,32]. Thus, once the initial aneuploidy is present the rate with which additional aneuploidy events appear is increased. The rate of aneuploid formation also increases during stress exposure. Within the first 12–24 hours of drug exposure, over 20% of C. albicans cells undergo unusual mitotic divisions that yield tetraploids/heterokaryons that then frequently give rise to aneuploids and, rarely, haploids [33]**, [4]. Hsp90 may also play an important role in aneuploid formation under stress conditions, as higher chromosome non-disjunction rates have been observed under stressors that demand increased levels of Hsp90 and that compromise kinetochore assembly [34]. Thus, extreme stress can lead to unconventional mitotic mechanisms of ploidy change under strong selective pressure that inhibits the growth of the original parent [33]**. Taken together, the appearance of aneuploids appears to be a natural consequence of cell cycle progression defects caused by stress itself, reminiscent of fitness associated recombination [35], stress-induced mutagenesis in bacteria (reviewed in [36]) and stress-induced loss of heterozygosity in yeasts [37].
Aneuploidy and stress: Is the benefit worth the cost?
Aneuploidy has the potential to affect phenotypic variation on both a general and specific level. A general signature of aneuploidy that is independent of the specific chromosome(s) involved has been proposed to involve slower progression through G1-phase [38,39] and elevated levels of proteotoxic stress relative to euploids [40]. Many aneuploid S. cerevisiae strains exhibit this feature, albeit to different degrees, but some do not [38]. Alterations in mRNA and protein levels generally correspond to the alterations in DNA copy number [41–44],though this effect may be buffered for certain genes and/or strain backgrounds [45] or be mitigated by post-translational regulatory effects on unlinked genes and their products [46]. Specific phenotypes linked to extra gene copies are often evident, though the effect of aneuploidy may be realized by the combined influence of multiple copy number changes [29**,47]. While the majority of possible aneuploidies likely have deleterious phenotypes (reviewed in [48]), selection should efficiently eliminate these deleterious aneuploidies from large populations, thereby enabling beneficial aneuploidies to remain.
If a favourable genotype can be acquired through aneuploidy, this may be expected to be a frequent route to adaptation, due to the higher rate of aneuploid formation relative to other types of mutations. Indeed, a high rate of beneficial aneuploidy has been identified under glucose limitation [49], drug stress [50], copper adaptation [51], adaptation to sulphate limitation [18,29**] and as a solution for gal7Δ strains that require a beneficial mutation to grow in galactose [52]. Furthermore, aneuploidy appears to be a more common event in diploids than in haploids [18], perhaps because the deleterious effects of an extra gene copy are less dramatic for diploids than for haploids. The propensity for specific aneuploidies to be selected as a result of specific environmental pressures has been exploited to measure chromosome gain rates in different genetic backgrounds [53]. The reliable production of aneuploids can also be exploited to set an “evolutionary trap”, by use of a drug that first enriches the population for a particular aneuploidy and a second drug that specifically inhibits the growth of cells that carry this aneuploidy.[54]**. As a general principle, aneuploidies are likely to incur a cost in non-selective environments, with the magnitude of this cost (and thus the stability of the aneuploidy) dependent on interaction between the environment, genes that are present in the aneuploidy, and the genetic background [44,51,55,56].
The degree of stress, independent of the environment, may also play a role in selecting for or against aneuplodies. Indeed, the degree to which fitness varied among otherwise isogenic aneuploid strains of S. cerevisiae scaled with the degree of stress across a range of conditions, suggesting that there may be a functional relationship between the degree of stress applied and the degree of phenotypic variation (including beneficial variation) [54]. This has important implications for therapeutic strategies, as it suggests that more severe drug treatments may stimulate more population diversity and may lead to progeny with a higher potential to adapt to the drug. The reverse may also be true, however, as aneuploidy may be seen less frequently under stressful conditions in multinucleate filamentous fungi [2].
As a result of both the general cost of aneuploidy and the specific chromosome × environment trade-offs, aneuploidy is likely to be a temporary solution, until more stable and specific genetic solutions arise. For example, S. cerevisiae cells that evolved under mild temperature stress first acquired an extra copy of Chr3, which facilitated faster growth at elevated temperature for 450 generations [57]**. Later, following further passage under elevated temperature, the aneuploidy was lost. A phenomenon reminiscent of this appeared in series of C. albicans clinical isolates from patients, where Chr5 aneuploidy often preceded the emergence of highly drug-resistant variants [1,58]. As aneuploidy is easily reversible, it may also function as a bet-hedging mechanism for toggling between two phenotypic states, as was seen for colony morphology phenotypes of S. cerevisiae isolates [2,59]*.
Conclusion
We propose that karyotypic variation can be both a non-selected cause and an adaptive response to stress that enables phenotypic variation to appear rapidly within populations. This is demonstrated by the response of C. albicans in the presence of the antifungal drug fluconazole: aneuploidy arises as a consequence of exposure to a drug, which stimulates the formation of multinucleate/tetraploid cells that produce aneuploid cells at a high rate [3,4,33]**. Specific forms of aneuploidy are also beneficial under fluconazole stress, and thus are maintained as a result of selection [12,60]. Importantly, karyotypic variants tend to be easily reversible, and thus under unstable environmental conditions they can rapidly appear and disappear from populations.
Karyotypic variants do not always incur a high fitness cost and relatively stable variants have been found during short and long term laboratory experimental evolution experiments, in a number of series of isolates from patients, and in nature [18,29,44,61–63]. However, due to their transient nature, sampling results and clinical sampling practices may under-estimate the true number of karyotypic variants. Similarly, in laboratory evolution experiments we likely miss a large degree of variation by focusing efforts primarily on the last, usually arbitrary, time-point. Finally, it is important to note that the majority of evolution experiments with S. cerevisiae have used haploid isolates that can undergo only chromosome gains, but not chromosome losses, and that may be less tolerant of additional chromosome copies than diploids. Not only is the appearance of aneuploidy likely to be more frequent in diploids or polyploids than in haploids [18], but aneuploidy well may have different fitness consequences as well [19]*.
In conclusion, ploidy and aneuploidy variants have the potential to arise frequently within populations, and may facilitate rapid adaptation. The emerging view is that the influence of aneuploidy is context dependent, and the fitness consequences depend on all aspects of a given circumstance: the environment, the genetic background, and the genes that are present in aneuploidy.
We apologize to the authors of many important studies whose work we did not have the space to discuss due to the concise nature of this article format.
We review recent studies of ploidy and aneuploidy variants and how they affect fitness.
Parasexual ploidy shifts appear in fungal microbial species in the absence of meiosis.
Ploidy shifts appear for cryptic reasons with few consistent selective advantages
Aneuploidy appears in a large proportion of cells exposed to an antifungal drug.
Specific aneuploidies cause adaptive phenotypes under specific growth conditions.
Acknowledgements
We thank Anna Selmecki for helpful discussions. This work was supported by the People Programme (Marie Curie Actions) the European Union's Seventh Framework Programme (FP7/2007–2013) REA grant agreement number 303635; by an ERC Advanced Award, number 340087, RAPLODAPT, grants from the Israel Science foundation (340/13.), and by the National Institute of Allergy and Infectious Disease (R01AI075096 and R01AI0624273) to JB. ACG was supported by fellowship awards from the National Sciences and Engineering Research Council of Canada, the Canadian Institutes for Health Research, and the Azrieli Foundation.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Albertin W, Marullo P. Polyploidy in fungi: evolution after whole-genome duplication. Proceedings of the Royal Society B Biological Sciences. 2012;279:2497–2509. doi: 10.1098/rspb.2012.0434. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Anderson CA, Roberts S, Zhang H, Kelly CM, Kendall A, Lee C, Gerstenberger J, Koenig AB, Kabeche R, Gladfelter AS. Ploidy variation in multinucleate cells changes under stress. Mol Biol Cell. 2015;26:1129–1140. doi: 10.1091/mbc.E14-09-1375.. This paper shows the surprising result that ploidy varies from 1N-4N among nuclei sharing a common cytomplasm in typically haploid multinucleate fungus Ashbya gossypii. The degree of ploidy variation was shown to increase with cell age and surprisingly, to decrease under stress.
- 3.Hickman MA, Zeng G, Forche A, Hirakawa MP, Abbey D, Harrison BD, Wang Y-M, Su C-H, Bennett RJ, Wang Y, et al. The “obligate diploid” Candida albicans forms mating-competent haploids. Nature. 2013;494:55–59. doi: 10.1038/nature11865. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Chang F-M, Ou T-Y, Cheng W-N, Chou M-L, Lee K-C, Chin Y-P, Lin C-P, Chang K-D, Lin C-T, Su C-H. Short-term exposure to fluconazole induces chromosome loss in Candida albicans: An approach to produce haploid cells. Fungal Genetics and Biology. 2014;70:68–76. doi: 10.1016/j.fgb.2014.06.009. [DOI] [PubMed] [Google Scholar]
- 5.Marr KA, Lyons CN, Ha K, Rustad TR, White TC. Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans. Antimicrobial Agents and Chemotherapy. 2001;45:52–59. doi: 10.1128/AAC.45.1.52-59.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Abbey DA, Funt J, Lurie-Weinberger MN, Thompson DA, Regev A, Myers CL, Berman J. YMAP : a pipeline for visualization of copy number variation and loss of heterozygosity in eukaryotic pathogens. Genome Medicine. 2014;6:1–15. doi: 10.1186/s13073-014-0100-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Okagaki LH, Wang Y, Ballou ER, O'Meara TR, Bahn YS, Alspaugh JA, Xue C, Nielsen K. Cryptococcal Titan Cell Formation Is Regulated by G-Protein Signaling in Response to Multiple Stimuli. Eukaryotic Cell. 2011;10:1306–1316. doi: 10.1128/EC.05179-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Zaragoza O, García-Rodas R, Nosanchuk JD, Cuenca-Estrella M, Rodríguez-Tudela JL, Casadevall A. Fungal Cell Gigantism Page 11 of 18 during Mammalian Infection. PLoS Pathog. 2010;6:e1000945. doi: 10.1371/journal.ppat.1000945. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Morrow CA, Fraser JA. Ploidy variation as an adaptive mechanism in human pathogenic fungi. Seminars in Cell and Developmental Biology. 2013;24:339–346. doi: 10.1016/j.semcdb.2013.01.008. [DOI] [PubMed] [Google Scholar]
- 10.Hughes TR, Roberts CJ, Dai HY, Jones AR, Meyer MR, Slade D, Burchard J, Dow S, Ward TR, Kidd MJ, et al. Widespread aneuploidy revealed by DNA microarray expression profiling. Nat Genet. 2000;25:333–337. doi: 10.1038/77116. [DOI] [PubMed] [Google Scholar]
- 11.Selmecki A, Forche A, Berman J. Aneuploidy and isochromosome formation in drug-resistant Candida albicans. Science. 2006;313:367–370. doi: 10.1126/science.1128242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Sionov E, Lee H, Chang YC, Kwon-Chung KJ. Cryptococcus neoformans Overcomes Stress of Azole Drugs by Formation of Disomy in Specific Multiple Chromosomes. PLoS Pathog. 2010;6:e1000848. doi: 10.1371/journal.ppat.1000848. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Reedy JL, Floyd AM, Heitman J. Mechanistic Plasticity of Sexual Reproduction and Meiosis in the Candida Pathogenic Species Complex. Current Biology. 2009;19:891–899. doi: 10.1016/j.cub.2009.04.058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Ni M, Feretzaki M, Li W, Floyd-Averette A, Mieczkowski P, Dietrich FS, Heitman J. PLOS Biology: Unisexual and Heterosexual Meiotic Reproduction Generate Aneuploidy and Phenotypic Diversity De Novo in the Yeast Cryptococcus neoformans. PLoS Biol. 2013;11:e1001653. doi: 10.1371/journal.pbio.1001653. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Gerstein AC, Chun H-JE, Grant A, Otto SP. Genomic convergence toward diploidy in Saccharomyces cerevisiae. PLoS Genet. 2006;2:e145. doi: 10.1371/journal.pgen.0020145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Hickman MA, Paulson C, Dudley AM, Berman J. Parasexual ploidy reduction drives population heterogeneity through random and transient aneuploidy in Candida albicans. Genetics. 2015 doi: 10.1534/genetics.115.178020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Bennett RJ, Johnson AD. Completion of a parasexual cycle in Candida albicans by induced chromosome loss in tetraploid strains. The EMBO Journal. 2003;22:2502–2515. doi: 10.1093/emboj/cdg235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Gresham D, Desai MM, Tucker CM, Jenq HT, Pai DA, Ward A, Desevo CG, Botstein D, Dunham MJ. The Repertoire and Dynamics of Evolutionary Adaptations to Controlled Nutrient-Limited Environments in Yeast. PLoS Genet. 2008;4:e1000303. doi: 10.1371/journal.pgen.1000303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Selmecki AM, Maruvka YE, Richmond PA, Guillet M, Shoresh N, Sorenson AL, De S, Kishony R, Michor F, Dowell R, et al. Polyploidy can drive rapid adaptation in yeast. Nature. 2015 doi: 10.1038/nature14187. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Seervai RNH, Jones SK, Hirakawa MP, Porman AM, Bennett RJ. Parasexuality and Ploidy Change in Candida tropicalis. Eukaryotic Cell. 2013;12:1629–1640. doi: 10.1128/EC.00128-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Gerstein AC, Otto SP. Cryptic fitness advantage: diploids invade haploid populations despite lacking any apparent advantage as measured by standard fitness assays. PLoS ONE. 2011;6:e26599. doi: 10.1371/journal.pone.0026599. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Gerstein AC, Otto SP. Ploidy and the causes of genomic evolution. J. Hered. 2009;100:571–581. doi: 10.1093/jhered/esp057. [DOI] [PubMed] [Google Scholar]
- 23. Zörgö E, Chwialkowska K, Gjuvsland AB, Garré E, Sunnerhagen P, Liti G, Blomberg A, Omholt SW, Warringer J. Ancient Evolutionary Trade-Offs between Yeast Ploidy States. PLoS Genet. 2013;9:e1003388. doi: 10.1371/journal.pgen.1003388.. The authors conducted an extensive comparison of haploid and diploid performance across a large number of environmental challenges. Importantly, although the authors show significant differences between haploids and diploids in the majority of environments, these differences did not always correspond to often-cited hypotheses about the types of environments where haploids or diploids are predicted to have an advantage.
- 24.Anderson J, Sirjusingh C. Haploidy, diploidy and evolution of antifungal drug resistance in Saccharomyces cerevisiae. Genetics. 2004;168:1915–1923. doi: 10.1534/genetics.104.033266. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Payen C, Sunshine AB, Ong GT, Pogachar JL, Zhao W, Dunham MJ. Empirical determinants of adaptive mutations in yeast experimental evolution. bioRxiv [Google Scholar]
- 26.Gerstein AC, Cleathero LA, Mandegar MA, Otto SP. Haploids adapt faster than diploids across a range of environments. Journal of Evolutionary Biology. 2010 doi: 10.1111/j.1420-9101.2010.02188.x. [DOI] [PubMed] [Google Scholar]
- 27.Gerstein AC, Kuzmin A, Otto SP. Loss-of-heterozygosity facilitates passage through Haldane’s sieve for Saccharomyces cerevisiae undergoing adaptation. Nature Communications. 2014;5:1–9. doi: 10.1038/ncomms4819. [DOI] [PubMed] [Google Scholar]
- 28.Gerstein AC. Mutational effects depend on ploidy level: all else is not equal. Biology Letters. 2012 doi: 10.1098/rsbl.2012.0614. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Sunshine AB, Payen C, Ong GT, Liachko I, Tan KM, Dunham MJ. The Fitness Consequences of Aneuploidy Are Driven by Condition-Dependent Gene Effects. PLoS Biol. 2015;13:e1002155. doi: 10.1371/journal.pbio.1002155.. This study analyzed aneuploid isolates that had been evolved in nutrient-limiting conditions. They found that the majority of the aneuploid isolates improved cellular fitness, had large fitness effect sizes and that their effect on fitness had different effects in different growth conditions. In addition, the authors developed a method to generate minichromosomes carrying an extra copy of chromosome segments from a selected gene to the telomere and they analyzed the effect of these artificially produced aneuploids on fitness measured as cell growth in batch cultures. Here as well, the aneuploids had large effects that depended upon the environmental conditions. Importantly, they were able to show that most of the effects, both positive and negative, were driven by a few genes on the minichromosome.
- 30.Zhu YO, Siegal ML, Hall DW, Petrov DA. Precise estimates of mutation rate and spectrum in yeast. Proc Natl Acad Sci US A. 2014;111:E2310–E2318. doi: 10.1073/pnas.1323011111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Bouchonville K, Forche A, Tang KES, Selmecki A, Berman J. Aneuploid Chromosomes Are Highly Unstable during DNA Transformation of Candida albicans. Eukaryotic Cell. 2009;8:1554–1566. doi: 10.1128/EC.00209-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Sheltzer JM, Blank HM, Pfau SJ, Tange Y, George BM, Humpton TJ, Brito IL, Hiraoka Y, Niwa O, Amon A. Aneuploidy drives genomic instability in yeast. Science. 2011;333:1026–1030. doi: 10.1126/science.1206412. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Harrison BD, Hashemi J, Bibi M, Pulver R, Bavli D, Nahmias Y, Wellington M, Sapiro G, Berman J. A Tetraploid Intermediate Precedes Aneuploid Formation in Yeasts Exposed to Fluconazole. PLoS Biol. 2014;12:e1001815. doi: 10.1371/journal.pbio.1001815.. This paper analyzed the effect of fluconazole on C. albicans cells by flow cytometry and time-lapse microscopy. They found that fluconazole caused a delay in cell cycle progression and the formation of ‘trimera’ cells with three cell compartments and four nuclei. Trimeras produced tetraploid progeny that subsequently gave rise to aneuploids. The entire process occurred within 12–24 hours and involved at least 10–20% of the population, Page 14 of 18 providing an explaination for why aneuploids are often seen in drug-treated isolates.
- 34.Chen G, Bradford WD, Seidel CW, Li R. Hsp90 stress potentiates rapid cellular adaptation through induction of aneuploidy. Nature. 2012 doi: 10.1038/nature10795. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Hadany L, Beker T. Fitness-associated recombination on rugged adaptive landscapes. Journal of Evolutionary Biology. 2003;16:862–870. doi: 10.1046/j.1420-9101.2003.00586.x. [DOI] [PubMed] [Google Scholar]
- 36.Galhardo RS, Hastings PJ, Rosenberg SM. Mutation as a Stress Response and the Regulation of Evolvability. Critical Reviews in Biochemistry and Molecular Biology. 2007;42:399–435. doi: 10.1080/10409230701648502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Forche A, Abbey D, Pisithkul T, Weinzierl MA, Ringstrom T, Bruck D, Petersen K, Berman J. Stress Alters Rates and Types of Loss of Heterozygosity in Candida albicans. mBio. 2011;2:e00129-11–e00129-11. doi: 10.1128/mBio.00129-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Thorburn RR, Gonzalez C, Brar GA, Christen S, Carlile TM, Ingolia NT, Sauer U, Weissman JS, Amon A. Aneuploid yeast strains exhibit defects in cell growth and passage through START. Mol Biol Cell. 2013;24:1274–1289. doi: 10.1091/mbc.E12-07-0520. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Rancati G, Pavelka N. Karyotypic changes as drivers and catalyzers of cellular evolvability: a perspective from non-pathogenic yeasts. Seminars in Cell and Developmental Biology. 2013;24:332–338. doi: 10.1016/j.semcdb.2013.01.009. [DOI] [PubMed] [Google Scholar]
- 40.Torres EM, Sokolsky T, Tucker CM, Chan LY, Boselli M, Dunham MJ, Amon A. Effects of Aneuploidy on Cellular Physiology and Cell Division in Haploid Yeast [Internet] Science. 2007;317:916–924. doi: 10.1126/science.1142210. [DOI] [PubMed] [Google Scholar]
- 41.Springer M, Weissman JS, Kirschner MW. A general lack of compensation for gene dosage in yeast. Molecular Systems Biology. 2010;6:368. doi: 10.1038/msb.2010.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Torres EM, Dephoure N, Panneerselvam A, Tucker CM, Whittaker CA, Gygi SP, Dunham MJ, Amon A. Identification of Aneuploidy-Tolerating Mutations. Cell. 2010;143:71–83. doi: 10.1016/j.cell.2010.08.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Pavelka N, Rancati G, Zhu J, Bradford WD, Saraf A, Florens L, Sanderson BW, Hattem GL, Li R. Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast. Nature. 2010;468:321–325. doi: 10.1038/nature09529. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Hirakawa MP, Martinez DA, Sakthikumar S, Anderson MZ, Berlin A, Gujja S, Zeng Q, Zisson E, Wang JM, Greenberg JM, et al. Genetic and phenotypic intra-species variation in Candida albicans. Genome Research. 2015;25:413–425. doi: 10.1101/gr.174623.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Hose J, Yong CM, Sardi M, Wang Z, Newton MA, Gasch AP. Dosage compensation can buffer copy-number variation in wild yeast. eLife. 2015;4 doi: 10.7554/eLife.05462. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Dephoure N, Hwang S, O'Sullivan C, Dodgson SE, Gygi SP, Amon A, Torres EM. Quantitative proteomic analysis reveals posttranslational responses to aneuploidy in yeast. eLife. 2014;3:e03023. doi: 10.7554/eLife.03023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Bonney ME, Moriya H, Amon A. Aneuploid proliferation defects in yeast are not driven by copy number changes of a few dosage-sensitive genes. Genes & Development. 2015;29:898–903. doi: 10.1101/gad.261743.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Siegel JJ, Amon A. New Insights into the Troubles of Aneuploidy. Annu. Rev. Cell. Biol. 2012;28:189–214. doi: 10.1146/annurev-cellbio-101011-155807. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Dunham MJ, Badrane H, Ferea T. Characteristic genome rearrangements in experimental evolution of Saccharomyces cerevisiae. 2002 doi: 10.1073/pnas.242624799. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Selmecki A, Gerami-Nejad M, Paulson C, Forche A, Berman J. An isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1. Mol Microbiol. 2008;68:624–641. doi: 10.1111/j.1365-2958.2008.06176.x. [DOI] [PubMed] [Google Scholar]
- 51.Gerstein AC, Ono J, Lo DS, Campbell ML, Kuzmin A, Otto SP. Too much of a good thing: the unique and repeated paths toward copper adaptation. Genetics. 2015;199:555–571. doi: 10.1534/genetics.114.171124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Sirr A, Cromie GA, Jeffery EW, Gilbert TL, Ludlow CL, Scott AC, Dudley AM. Allelic Variation, Aneuploidy and Non-Genetic Mechanisms Suppress a Monogenic Trait in Yeast. Genetics. 2014 doi: 10.1534/genetics.114.170563.. This study developed a new method, FACS-QTL to more easily isolate large numbers of haploid progeny for bulk segregant analysis. Progeny that grew under selective conditions were analyzed by RAD-seq to identify regions of biased inheritance. One of the unexpected results was that aneuploidy was a frequent (51% of progeny) mechanism for suppression of a mutant phenotype. Furthermore, aneuploid chromosomes carrying specific alleles of the relevant gene were present in biased ratios. This all supports the idea that aneuploidy provides a selective advantage primarily due to the extra Page 16 of 18 copies of specific genes or combinations of genes present on the aneuploid chromosomes.
- 53.Covo S, Puccia CM, Argueso JL, Gordenin DA, Resnick MA. The sister chromatid cohesion pathway suppresses multiple chromosome gain and chromosome amplification. Genetics. 2014;196:373–384. doi: 10.1534/genetics.113.159202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Chen G, Mulla WA, Kucharavy A, Tsai H-J, Rubinstein B, Conkright J, McCroskey S, Bradford WD, Weems L, Haug JS, et al. Targeting the adaptability of heterogeneous aneuploids. Cell. 2015;160:771–784. doi: 10.1016/j.cell.2015.01.026.. Some diseases or pathogens often develop resistance to a drug via a specific aneuploidy. In this study, the authors screened for drugs that specifically affect these drug-resistant aneuploids (and not euploids), to design an “evolutionary trap” strategy for combination drug therapies using yeast and mammalian examples.
- 55.Hill JA, O’Meara TR, Cowen LE. Fitness Trade-Offs Associated with the Evolution of Resistance to Antifungal Drug Combinations. CellReports. 2015;10:809–819. doi: 10.1016/j.celrep.2015.01.009. [DOI] [PubMed] [Google Scholar]
- 56.Semighini CP, Averette AF, Perfect JR, Heitman J. Deletion of Cryptococcus neoformans AIF ortholog promotes chromosome aneuploidy and fluconazole-resistance in a metacaspase-independent manner. PLoS Pathog. 2011;7:e1002364. doi: 10.1371/journal.ppat.1002364. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Yona AH, Manor YS, Herbst RH, Romano GH, Mitchell A, Kupiec M, Pilpel Y, Dahan O. Chromosomal duplication is a transient evolutionary solution to stress. Proc Natl Acad Sci US A. 2012;109:21010–21015. doi: 10.1073/pnas.1211150109.. This manuscript describes the evolution of high temperature tolerance in bakers’ yeast and finds that aneuploidy of chromosome III provides a transient beneficial solution that is eventually displaced by other mutations.
- 58. Ford CB, Funt JM, Abbey D, Issi L, Guiducci C, Martinez DA, Delorey T, Li BY, White TC, Cuomo C, et al. The evolution of drug resistance in clinical isolates of Candida albicans. eLife. 2015;4:e00662. doi: 10.7554/eLife.00662.. This large scale study of different Candida albicans isolates collected over time from the same individual patients determined that some genes are found to Page 17 of 18 be mutated in isolates from different patients and to persist within later isolates from the same patients. In contrast, aneuploidies appeared transiently but did not persist over time. Because these isolates are not necessarily direct descendents of one another, it will be important for future studies to analyze multiple independent isolates from the same patient at each time point.
- 59.Tan Z, Hays M, Cromie GA, Jeffery EW, Scott AC, Ahyong V, Sirr A, Skupin A, Dudley AM. Aneuploidy underlies a multicellular phenotypic switch. Proc Natl Acad Sci US A. 2013;110:12367–12372. doi: 10.1073/pnas.1301047110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Selmecki AM, Dulmage K, Cowen LE, Anderson JB, Berman J. Acquisition of aneuploidy provides increased fitness during the evolution of antifungal drug resistance. PLoS Genet. 2009;5:e1000705. doi: 10.1371/journal.pgen.1000705. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Hope EA, Dunham MJ. Ploidy-Regulated Variation in Biofilm-Related Phenotypes in Natural Isolates of Saccharomyces cerevisiae. G3: Genes|Genomes|Genetics. 2014;4:1773–1786. doi: 10.1534/g3.114.013250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Wohlbach DJ, Rovinskiy N, Lewis JA, Sardi M, Schackwitz WS, Martin JA, Deshpande S, Daum CG, Lipzen A, Sato TK, et al. Comparative genomics of Saccharomyces cerevisiae natural isolates for bioenergy production. Genome Biol Evol. 2014;6:2557–2566. doi: 10.1093/gbe/evu199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Ezov TK, Boger-Nadjar E, Frenkel Z, Katsperovski I, Kemeny S, Nevo E, Korol A, Kashi Y. Molecular-Genetic Biodiversity in a Natural Population of the Yeast Saccharomyces cerevisiae From “Evolution Canyon”: Microsatellite Polymorphism, Ploidy and Controversial Sexual Status. Genetics. 2006;174:1455–1468. doi: 10.1534/genetics.106.062745. [DOI] [PMC free article] [PubMed] [Google Scholar]

